Many bacterial infections present similar symptoms. Microbial testing is one of the important parameters considered for potability of water. E. coli is one of the dreaded bacterium causes harmful water and food borne diseases. Pathogenic E. coli represent a phenotypically diverse group of pathogens and no single method or approach can be used to detect or isolate all of the pathotypes of concern E. Coli diagnostics testing is usually conducted by an accurate history, physical exam, and analysis of the fecal sample. Other tests include PCR and immunofluorescence tests. The CDC suggests that, although the immunological test is better than bacterial culture techniques, both culture and immunological tests should be conducted at the same time.
The global E. coli diagnostics testing market report estimates the market size (Revenue USD million – 2014 to 2021) and composition of this market in terms of clinical testing methods and end users such as hospitals, diagnostic labs and physician office along with forecasts growth trends (CAGR% – 2017 to 2021).
The global E. coli diagnostics testing market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global E. coli diagnostics testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global E. coli diagnostics testing market and included in this report are Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., IDEXX Laboratories, Inc., Danaher Corporation, Meridian Bioscience, Inc., CPI International, Inc., and Thermo Fisher Scientific, Inc